DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026

Go back to DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026
(NASDAQ: DMAC) Delayed: 5.46 +0.13 (2.44%)
Previous Close $5.33    52 Week High
Open $5.32    52 Week Low
Day High $5.47    P/E N/A 
Day Low $5.25    EPS
Volume 148,688